Lumos Diagnostics Holdings Ltd (LDX) — Cash Flow Reinvestment Rate

Latest as of December 2025: 0.24x

Lumos Diagnostics Holdings Ltd (LDX) has a Cash Flow Reinvestment Rate of 0.24x as of December 2025, reinvesting AU$189.41K (capex AU$189.41K ) from operating cash flow of AU$778.03K. Explore Lumos Diagnostics Holdings Ltd capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.24x

(Capex + Investments) / Operating CF

Total Reinvested

AU$189.41K

Capex + Investments

Operating Cash Flow

AU$778.03K

AUD

Capital Expenditures

AU$189.41K

AUD

Lumos Diagnostics Holdings Ltd Cash Flow Reinvestment Rate (2023–2023)

Historical reinvestment intensity for Lumos Diagnostics Holdings Ltd across 1 annual periods. Also explore Lumos Diagnostics Holdings Ltd total assets for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Lumos Diagnostics Holdings Ltd (2023–2023)

Year-by-year capital reinvestment analysis for Lumos Diagnostics Holdings Ltd. For live market cap and broader valuation context, see Lumos Diagnostics Holdings Ltd stock valuation.

Year	Reinvestment Rate	Total Reinvested (AUD)	Operating CF	Capex	YoY Change
2023	0.21x	AU$196.00K	AU$946.00K	AU$98.00K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow